# Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

> **NCT01389700** · PHASE2 · TERMINATED · sponsor: **Sanofi** · enrollment: 7 (actual)

## Conditions studied

- Infection Prophylaxis

## Interventions

- **DRUG:** SAR279356
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01389700
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Difficulty in patient recruitment in the participating sites
- **Last updated:** 2014-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01389700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01389700, "Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01389700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*